주요서비스 바로가기
본문 바로가기
매체정보 바로가기
로그인 바로가기
기사검색 바로가기
전체서비스 바로가기
상단영역
UPDATE : 2024-04-26 16:52 (Fri)
Home
Log in
Join
전체메뉴
기사검색
검색
본문영역
All articles
목록
(
총 :
345 )
기사목록 보기 형태
제목형
요약형
포토형
Guerbet Korea under fire for exploiting monopoly drug
Nam Doo-hyun
2018.04.26 14:46
GC Pharma has most patents among large drug suppliers
Nam Doo-hyun
2018.04.26 11:08
Pharma shares on the rise since early this year
Nam Doo-hyun
2018.04.25 13:50
3 Korean pipelines listed in 537 new drug candidates in US
Nam Doo-hyun
2018.04.24 11:19
Insulin Toujeo beats Tresiba in patient number
Nam Doo-hyun
2018.04.23 15:56
Korean units of GSK, Pfizer send highest dividends to parent firms
Nam Doo-hyun
2018.04.20 14:40
Biotech stocks could be overpriced: analysts
Nam Doo-hyun
2018.04.19 13:27
AstraZeneca up, Novartis down in Q1 outpatient prescriptions
Nam Doo-hyun
2018.04.18 14:42
ViroMed confirms VM202’s pain control in animal test
Nam Doo-hyun
2018.04.18 11:25
‘Genexine’s pipelines worth more than ₩3 trillion’
Nam Doo-hyun
2018.04.16 15:20
Obesity drug Saxenda’s sheds ‘1-year effect’ stigma
Nam Doo-hyun
2018.04.11 13:29
CG Bio wins nod for 3D printed artificial cheekbones
Nam Doo-hyun
2018.04.10 14:57
처음
이전
이전
이전
11
12
13
14
15
16
17
18
19
20
다음
다음
다음
끝
위로
전체메뉴
All
Hospital
Pharma
Bio
All
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
All
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
ASCO 2020 Highlights
Special Series in Celebration of KBR’s 4th Anniversary
KBR Covering RSNA 2021
Special Series in Celebration of KBR’s 5th Anniversary
Special Report on EULAR 2022
[Top K-Pharma Analysis]
BIO 2023
Opinion
All
Reporter’s Notebook
Journalist’s Column
Congratulatory Remarks
Sponsored
전체메뉴닫기